Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Cardiovascular Diabetology|January 9, 2024
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims databasePatrick Blin, Michael Joubert, Patrick Jourdain, et al.Kidney International Reports|April 30, 2025
Safety and Efficacy of Oral Direct Factor Xa Inhibitors in Patients With Nephrotic Syndrome: Results From a National Retrospective StudyCaroline Arches, Arwa Jalal-Eddine, Dimitri Titeca-Beauport, et al.Diabetes Care|March 14, 2014
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE CohortPierre-Jean Saulnier, Elise Gand, Stéphanie Ragot, et al.Diabetes Care|May 26, 2016
Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 DiabetesStéphanie Ragot, Pierre-Jean Saulnier, Gilberto Velho, et al.Diabetologia|August 6, 2016
ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patientsBarnabas Gellen, Nathalie Thorin-Trescases, Philippe Sosner, et al.Journal of Diabetes and Its Complications|May 24, 2011
Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trialEmmanuel Villar, Michel Lièvre, Michèle Kessler, et al.Kidney International Reports|September 18, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous NephropathyBrad H Rovin, Pierre M Ronco, Jack F M Wetzels, et al.Intensive Care Medicine|June 5, 2016
Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recoveryAnne-Sophie Truche, Michael Darmon, Sébastien Bailly, et al.Transplantation|November 12, 2015
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled TrialBénédicte Sautenet, Gilles Blancho, Mathias Büchler, et al.Journal of Nephrology|July 5, 2021
Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndromeMarie-Sophie Meuleman, Sophie Guilmin-Crépon, Aurélie Hummel, et al.Pageof 5